Arana Therapeutics makes appointment
This article was originally published in Scrip
Executive Summary
The Australian antibody firm Arana Therapeutics has appointed Dr Alan Scott vice-president for clinical research. Dr Scott joins from Quintiles Transnational, where he held responsibility for initiating trials in the Asia-Pacific region; he will report to Arana's chief medical officer Dr David Fuller.